Advanced Malignant Solid Tumors Completed Phase 1 Trials for Erlotinib (DB00530)

IndicationStatusPhase
DBCOND0036787 (Advanced Malignant Solid Tumors)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00884845Trial of PM02734 Administered in Combination With Erlotinib in Patients With Advanced Malignant Solid TumorsTreatment